| Patent Number |
Title Of Patent |
Date Issued |
| 6962920 |
Pyrimidine derivatives and methods of making and using these derivatives |
November 8, 2005 |
| This invention discloses pyrimidine derivatives, and pharmaceutically acceptable salts and prodrugs thereof, useful in therapeutically and/or prophylactically treating patients with an illness. Such illnesses include cancer, and secondary infections caused by Pneumocystis carinii and |
| 6770652 |
Multiple acting anti-angiogenic and cytotoxic compounds and methods for using the same |
August 3, 2004 |
| This invention discloses pyrrolo pyrimidine compounds, and pharmaceutically acceptable salts, solvates and prodrugs thereof, of the following formula (3): ##STR1##These compounds are useful in therapeutically and/or prophylactically treating patients with cancer by inhibiting recepto |
| 6696455 |
Pyrimidine derivatives and methods of making and using these derivatives |
February 24, 2004 |
| This invention discloses compounds, and pharmaceutically acceptable salts thereof, useful in therapeutically and/or prophylactically treating patients with an illness. Such illnesses include cancer, and secondary infections caused by Pneumocystis carinii and Toxoplasmosis gondii in i |
| 6537999 |
Pyrimidine derivatives and methods of making and using these derivatives |
March 25, 2003 |
| This invention discloses pyrimidine derivatives, and pharmaceutically acceptable salts and prodrugs thereof, of the following formula: ##STR1## wherein L and M are selected from the group consisting of carbon and CH, the chemical bond between L and M is selected from the group consist |
| 6518426 |
Pyrimidine derivatives and methods of making and using these derivatives |
February 11, 2003 |
| Novel pyrrolo[3,2-d]pyrimidine derivatives of the following general formula ##STR1##are disclosed. These compounds are useful in the treatment of bacterial infections such as Toxoplasmosis gondii and Pneumocystis carinii, and various types of cancer, through their action on dihydrofolate |
| 6423720 |
Pyrimidine compounds and methods for making and using the same |
July 23, 2002 |
| This invention discloses compounds, and pharmaceutically acceptable salts, solvates and prodrugs thereof, useful in therapeutically and/or prophylactically treating patients with an illness. Such illnesses include cancer, and secondary infections caused by Pneumocystis carinii, Toxop |
| 6420370 |
Pyrimidine derivatives and method of making and using derivatives |
July 16, 2002 |
| This invention discloses compounds, and pharmaceutically acceptable salts thereof, useful in therapeutically and/or prophylactically treating patients with an illness. Such illnesses include cancer, and secondary infections caused by Pneumocystis carinii and Toxoplasmosis gondii in i |
| 6221872 |
Pyrimidine derivatives and methods of making and using these derivatives |
April 24, 2001 |
| This invention discloses compounds, and pharmaceutically acceptable salts thereof, useful in therapeutically and/or prophylactically treating patients with an illness. Such illnesses include cancer, and secondary infections caused by Pneumocystis carinii and Toxoplasmosis gondii in i |
| 6114339 |
Derivatives of pyrido [2,3-D] and [3,2-D] pyrimidine method of using these derivatives |
September 5, 2000 |
| The invention also discloses compounds and pharmaceutically acceptable salts having the generic formula (2) ##STR1## wherein X and Y may be the same or different and are selected from the group consisting of OH and NH.sub.2 ; wherein Z is one of either nitrogen or carbon and Q is |
| 6103727 |
Pyrimidine derivatives and methods of making and using these derivatives |
August 15, 2000 |
| This invention discloses compounds, and pharmaceutically acceptable salts thereof, useful in therapeutically and/or prophylactically treating patients with an illness. Such illnesses include cancer, and secondary infections caused by Pneumocystis carinii and Toxoplasmosis gondii in i |
| 6096750 |
Furopyrimidines and methods of making and using the same derivatives |
August 1, 2000 |
| This invention discloses compounds, and pharmaceutically acceptable salts thereof, useful in therapeutically and/or prophylactically treating patients with an illness. Such illnesses include cancer, and secondary infections caused by Pneumocystis carinii and Toxoplasmosis gondii in i |
| 6077844 |
Pyrimidine derivatives and methods of making and using these derivatives |
June 20, 2000 |
| This invention discloses compounds, and pharmaceutically acceptable salts thereof, useful in therapeutically and/or prophylactically treating patients with an illness. Such illnesses include cancer, and secondary infections caused by Pneumocystis carinii and Toxoplasmosis gondii in i |
| 5958930 |
Pyrrolo pyrimidine and furo pyrimidine derivatives |
September 28, 1999 |
| This invention discloses compounds, and pharmaceutically acceptable salts thereof, useful in therapeutically and/or prophylactically treating patients with an illness. Such illnesses include cancer, and secondary infections caused by Pneumocystis carinii and Toxoplasmosis gondii in i |
| 5939420 |
Pyrrolo[2,3d]derivatives |
August 17, 1999 |
| Pyrrolo[2,3-d]pyrimidine derivatives, and pharmaceutical acceptable salts thereof, useful in therapeutically and/or prophylactically treating patients with an illness are disclosed. |
| 5877178 |
Pyrimidine derivatives and methods of making and using these derivatives |
March 2, 1999 |
| This invention discloses compounds, and pharmaceutically acceptable salts thereof, useful in therapeutically and/or prophylactically treating patients with an illness. Such illnesses include cancer, and secondary infections caused by Pneumocystis carinii and Toxoplasmosis gondii in i |
| 5866580 |
Quinazoline derivatives and methods of using the same |
February 2, 1999 |
| The present invention discloses compounds, and pharmaceutically acceptable salts thereof, having the following formula (5): ##STR1## wherein X and Y are the same or different and are either OH or NH.sub.2 ; wherein A is either nitrogen, CH or sulfur, and B equals CH when A is sul |
| 5863920 |
Furo-pyrimidine derivatives and methods of making and using these derivatives |
January 26, 1999 |
| This invention discloses furo-pyrimidine compounds, and pharmaceutically acceptable salts thereof, useful in therapeutically and/or prophylactically treating patients with an illness. Such illnesses include cancer, and secondary infections caused by Pneumocystis carinii and Toxoplasm |
| 5736547 |
Derivatives of pyrido [2,3-D] and [3,2-D] Pyrimidine and quinazoline and method of using these d |
April 7, 1998 |
| The invention discloses species compounds (4) and (5) and methods of using these compounds for therapeutically treating a patient for an illness selected from the group consisting of infection by Pneumocystis carinii and Toxoplasmosis gondii. ##STR1## In compounds (4) and (5) X a |
| 5508281 |
Derivatives of pyrido [2,3-d] and [3,2-d] pyrimidine and methods of using these derivatives |
April 16, 1996 |
| The invention discloses generic compound (2) and its analog (6) and pharmaceutically acceptable salts and methods of using these compounds for therapeutically and prophylactically treating a patient for an illness consisting of the group of Pneumocystis carinii and Toxoplasmosis gondii |
